Cargando…
Metformin-Induced Hepatotoxicity
Autores principales: | Miralles-Linares, Francisco, Puerta-Fernandez, Susana, Bernal-Lopez, M. Rosa, Tinahones, Francisco J., Andrade, Raul J., Gomez-Huelgas, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322705/ https://www.ncbi.nlm.nih.gov/pubmed/22355024 http://dx.doi.org/10.2337/dc11-2306 |
Ejemplares similares
-
Response to Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673
por: Boronat, Mauro, et al.
Publicado: (2011) -
Comment on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Barbour, Linda A., et al.
Publicado: (2012) -
Comment on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Lau, Sue Mei
Publicado: (2012) -
Response to Comments on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Rowan, Janet A., et al.
Publicado: (2012) -
Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Ramos-Zavala, Maria G., et al.
Publicado: (2012)